Cardiovascular Systems (CSII) Getting Somewhat Favorable Media Coverage, Report Finds
Media stories about Cardiovascular Systems (NASDAQ:CSII) have been trending somewhat positive this week, according to Accern Sentiment. Accern identifies positive and negative news coverage by reviewing more than twenty million news and blog sources. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. Cardiovascular Systems earned a media sentiment score of 0.12 on Accern’s scale. Accern also assigned media headlines about the medical device company an impact score of 46.5452707239531 out of 100, meaning that recent news coverage is somewhat unlikely to have an impact on the company’s share price in the immediate future.
Here are some of the news stories that may have effected Accern Sentiment’s analysis:
- -$0.02 Earnings Per Share Expected for Cardiovascular Systems Inc (CSII) This Quarter (americanbankingnews.com)
- Cardiovascular Systems, Inc. and OrbusNeich Announce FDA Clearance of the First and Only 1.0mm Coronary Balloon in the U.S. (markets.financialcontent.com)
- BRIEF-Cardiovascular Systems Says OrbusNeich 1.0mm Sapphire II PRO Coronary Balloon Granted FDA Clearance (feeds.reuters.com)
- Champlain Investment Partners LLC Purchases 396,145 Shares of Cardiovascular Systems Inc (CSII) (americanbankingnews.com)
- Cortina Asset Management LLC Sells 98,118 Shares of Cardiovascular Systems Inc (CSII) (americanbankingnews.com)
A number of research analysts recently issued reports on CSII shares. Zacks Investment Research upgraded Cardiovascular Systems from a “sell” rating to a “hold” rating in a report on Monday, November 13th. BidaskClub downgraded Cardiovascular Systems from a “sell” rating to a “strong sell” rating in a report on Wednesday, December 27th. William Blair restated a “market perform” rating on shares of Cardiovascular Systems in a report on Thursday, December 21st. Needham & Company LLC downgraded Cardiovascular Systems from a “buy” rating to a “hold” rating and reduced their price target for the company from $33.11 to $23.00 in a report on Friday, December 15th. Finally, Raymond James Financial restated a “hold” rating on shares of Cardiovascular Systems in a report on Monday, December 4th. Three research analysts have rated the stock with a sell rating, five have given a hold rating and one has assigned a buy rating to the stock. The stock currently has an average rating of “Hold” and a consensus target price of $27.00.
Cardiovascular Systems (NASDAQ:CSII) last announced its quarterly earnings results on Wednesday, February 7th. The medical device company reported ($0.01) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.04) by $0.03. Cardiovascular Systems had a negative return on equity of 0.50% and a negative net margin of 1.62%. The company had revenue of $52.63 million for the quarter, compared to the consensus estimate of $53.39 million. During the same quarter in the previous year, the business earned $0.03 EPS. Cardiovascular Systems’s revenue was up 5.2% compared to the same quarter last year. equities analysts forecast that Cardiovascular Systems will post -0.07 earnings per share for the current year.
TRADEMARK VIOLATION NOTICE: This piece of content was posted by Daily Political and is the property of of Daily Political. If you are viewing this piece of content on another website, it was illegally copied and republished in violation of international copyright legislation. The correct version of this piece of content can be accessed at https://www.dailypolitical.com/2018/03/03/cardiovascular-systems-csii-getting-somewhat-favorable-media-coverage-report-finds.html.
Cardiovascular Systems Company Profile
Cardiovascular Systems, Inc is a medical technology company. The Company is engaged in treating patients suffering from peripheral and coronary artery diseases, including those with arterial calcium. The Company develops an orbital atherectomy technology for both peripheral and coronary commercial applications.
Receive News & Ratings for Cardiovascular Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardiovascular Systems and related companies with MarketBeat.com's FREE daily email newsletter.